Pattern of Intravenous Proton Pump Inhibitors Use in ICU and Non-ICU Setting: A Prospective Observational Study

Alsultan, Mohammed S.; Mayet, Ahmed Y.; Malhani, Areej A.; Alshaikh, Mashael K.
October 2010
Saudi Journal of Gastroenterology;Oct2010, Vol. 16 Issue 4, p275
Academic Journal
Background/Aim: The use of intravenous acid-suppressive therapy for stress ulcer prophylaxis in critically ill patients with specific risk factors has been recommended for over a decade. However, there is a lack of supporting data regarding the extension of such therapy to non-critically ill patients (non-ICU). The aim of this study was to compare appropriate indications with current practicing patterns in adult non- ICU and ICU patients, contributing factors and financial impact of inappropriate use. Materials and Methods: A prospective cross-sectional study was carried out at a tertiary teaching Hospital in Riyadh, Saudi Arabia. For a period of 4 consecutive months, all hospitalized patients on IV PPI, aged 18 and above, were identified. A concise listing of indications considered appropriate for the use of IV PPI was pre-defined based on material from available literature and guidelines. Results: A total of 255 patients received IV PPI. Inappropriate use of IV PPI was significantly higher in non-ICU (71.7%) than in ICU (19.8%) patients (P=0.01). The most common cause for inappropriate use in non-ICU patients was stress ulcer prophylaxis (SUP). In ICU patients, appropriate indicators for IV PPI were SUP (47.9%), PUD (11.5%), and the UGIB (20.8%). There was a high association between appropriate uses of IV PPI with respect to endoscopic procedure and also between appropriate uses of IV PPI to subsequent discharge with oral PPI in non-ICU patients. The total estimated direct cost (drug acquisition cost) for inappropriate use of IV PPI during the study period was 11,000 US dollars. Conclusion: Inappropriate IV PPI utilization was predominant in non-ICU patients, mostly for stress ulcer prophylaxis that leads to a waste of resources. Applying appropriate policies, procedures and evidence-based guidelines, educated physicians and surgeons can clearly limit inappropriate IV PPI use.


Related Articles

  • Proton pump inhibitors for acid suppression in the intensive care unit: Formulary considerations. Devlin, John W. // American Journal of Health-System Pharmacy;5/15/2005 Supplement 2, Vol. 62, pS24 

    Purpose. The rationale for limiting the proton pump inhibitor (PPI) products included in an institutional formulary, factors to consider when making formulary decisions about PPI products, the results and limitations of cost-effectiveness analyses of PPI therapy in critically ill patients, the...

  • Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress. Lenz, Kurt; Buder, Robert; Firlinger, Fritz; Lohr, Gerald; Voglmayr, Martin // Wiener Klinische Wochenschrift;Jan2015, Vol. 127 Issue 1/2, p51 

    Background: The incidence of upper gastrointestinal bleeding from stress ulcers has decreased within the last 30 years. Improvements in intensive care medicine including advanced equipment for artificial ventilation, better sedoanalgesic therapies, and the use of stress ulcer prophylaxis are...

  • How Do PPIs Affect Patients with Bleeding Ulcers? Shaughnessy, Allen F. // American Family Physician;8/15/2005, Vol. 72 Issue 4, p683 

    Presents the results of a case study regarding the effectiveness of proton pump inhibitor (PPI) on patients with bleeding peptic ulcers. Factor which enhances platelet function and inhibit fibrolysis in patients with an acute bleeding peptic ulcer; Effect of PPI treatment on mortality rates...

  • Proton Pump Inhibitors: An Update. Vanderhoff, Bruce T.; Tahboub, Rundsarah M. // American Family Physician;7/15/2002, Vol. 66 Issue 2, p273 

    Presents an update on proton pump inhibitors. Pharmacology; Side effects and precautions; Dosage and administration.

  • Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Grube, Rebekah R. Arthur; May, D. Byron // American Journal of Health-System Pharmacy;7/1/2007, Vol. 64 Issue 13, p1396 

    Purpose. A review is presented of the evidence behind the current use of therapies for the prevention of stress-related mucosal disease and bleeding in the non-intensive care unit (ICU), general medicine population. Summary. The use of proton pump inhibitors and histamine H2-receptor antagonists...

  • Effect of rebamipide on quality of peptic ulcer healing in rat. Zhu Qi; Li Jie; Cao Haixia; Zhao Xiaoying; Qi, Zhu; Jie, Li; Haixia, Cao; Xiaoying, Zhao // Digestive Diseases & Sciences;Sep2009, Vol. 54 Issue 9, p1876 

    The aim of this study is to elucidate the effects and the mechanism of rebamipide, omeprazole, and their combination treatment on quality of peptic ulcer healing (QOUH). Peptic ulcer models were induced by acetic acid exposure of the serosa of rat stomach. Forty Sprague-Dawley (SD) rats were...

  • Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers. Khek Yu Ho; Kuan, Arlene; ZaƱo, Felix; Khean Lee Goh; Mahachai, Varocha; Dong Yeon Kim; Hwan Min Yoon // Journal of Gastroenterology;2009, Vol. 44 Issue 7, p697 

    Ilaprazole (IY-81149) is a new proton-pump inhibitor (PPI) not previously studied in human patients with ulcer disease. This study evaluated and compared it with a reference PPI, omeprazole, in the treatment of gastric and duodenal ulcers. This was a double-blind, parallel, randomized study....

  • Proton pump inhibitors are the preferred treatment for ulcers. Zablocki, Elaine // Managed Healthcare Executive;Apr2004, Vol. 14 Issue 4, p48 

    Evaluates the use of proton pump inhibitors to ulcer treatment. Analysis of the symptoms of peptic ulcer; Reduction of stomach acid; Drugs for peptic ulcers.

  • proton pump inhibitors. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p634 

    An encyclopedia entry for "proton pump inhibitors" is presented. It refers to a type of ulcer-healing drug used to treat peptic ulcers.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics